These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 25201732

  • 1. Anti-osteopontin monoclonal antibody prevents ovariectomy-induced osteoporosis in mice by promotion of osteoclast apoptosis.
    Zhang B, Dai J, Wang H, Wei H, Zhao J, Guo Y, Fan K.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):795-800. PubMed ID: 25201732
    [Abstract] [Full Text] [Related]

  • 2. Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway.
    Li F, Sun X, Ma J, Ma X, Zhao B, Zhang Y, Tian P, Li Y, Han Z.
    Biochem Biophys Res Commun; 2014 Sep 26; 452(3):629-35. PubMed ID: 25181344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Potent inhibitory effect of Foeniculum vulgare Miller extract on osteoclast differentiation and ovariectomy-induced bone loss.
    Kim TH, Kim HJ, Lee SH, Kim SY.
    Int J Mol Med; 2012 Jun 26; 29(6):1053-9. PubMed ID: 22447109
    [Abstract] [Full Text] [Related]

  • 5. YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.
    Wang JW, Yeh CB, Chou SJ, Lu KC, Chu TH, Chen WY, Chien JL, Yen MH, Chen TH, Shyu JF.
    J Bone Miner Metab; 2018 Sep 26; 36(5):508-518. PubMed ID: 28983668
    [Abstract] [Full Text] [Related]

  • 6. Sphingosylphosphorylcholine blocks ovariectomy-induced bone loss by suppressing Ca2+ /calmodulin-mediated osteoclast differentiation.
    Lee HY, Cho KM, Kim MK, Lee M, Kim H, Choi CY, Kim KK, Park JS, Kim HH, Bae YS.
    J Cell Mol Med; 2021 Jan 26; 25(1):473-483. PubMed ID: 33230972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M, Luong-Nguyen NH, Baptist M, Cortesi R, Zumstein-Mecker S, Kossida S, O'Reilly T, Lane H, Susa M.
    Bone; 2004 Nov 26; 35(5):1144-56. PubMed ID: 15542040
    [Abstract] [Full Text] [Related]

  • 9. Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone.
    Kato N, Kitahara K, Rittling SR, Nakashima K, Denhardt DT, Kurosawa H, Ezura Y, Noda M.
    J Endocrinol; 2007 Apr 26; 193(1):171-82. PubMed ID: 17400814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
    Zhao Y, Huai Y, Jin J, Geng M, Li JX.
    Menopause; 2011 Jun 26; 18(6):690-7. PubMed ID: 21228726
    [Abstract] [Full Text] [Related]

  • 12. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI, Landao-Bassonga E, Ralston SH.
    Bone; 2010 Apr 26; 46(4):1089-99. PubMed ID: 20096813
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss.
    Li JX, Liu J, He CC, Yu ZY, Du Y, Kadota S, Seto H.
    Maturitas; 2007 Sep 20; 58(1):59-69. PubMed ID: 17658706
    [Abstract] [Full Text] [Related]

  • 15. Isosteviol Derivative Inhibits Osteoclast Differentiation and Ameliorates Ovariectomy-Induced Osteoporosis.
    Tzeng HE, Huang PH, Tsai CH, Tsay GJ, Lee YJ, Huang TJ, Lin TH, Chiu YM, Wu YY.
    Sci Rep; 2018 Jul 25; 8(1):11190. PubMed ID: 30046042
    [Abstract] [Full Text] [Related]

  • 16. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
    Fan K, Dai J, Wang H, Wei H, Cao Z, Hou S, Qian W, Wang H, Li B, Zhao J, Xu H, Yang C, Guo Y.
    Arthritis Rheum; 2008 Jul 25; 58(7):2041-52. PubMed ID: 18576331
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the antiosteoporotic potential of Cimicifuga heracleifolia in female mice.
    Ahn BS, Yang M, Jang H, Lee HJ, Moon C, Kim JC, Jung U, Jo SK, Jang JS, Kim SH.
    Phytother Res; 2012 May 25; 26(5):663-8. PubMed ID: 21987388
    [Abstract] [Full Text] [Related]

  • 18. Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.
    Jun AY, Kim HJ, Park KK, Son KH, Lee DH, Woo MH, Kim YS, Lee SK, Chung WY.
    Fitoterapia; 2012 Dec 25; 83(8):1523-31. PubMed ID: 22981503
    [Abstract] [Full Text] [Related]

  • 19. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS, Sengupta S, Sharma S, Singh MM.
    J Steroid Biochem Mol Biol; 2006 Aug 25; 100(4-5):117-28. PubMed ID: 16797179
    [Abstract] [Full Text] [Related]

  • 20. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT, Kawatani M, Kato M, Shinki T, Yonezawa T, Kanoh N, Nakagawa H, Takami M, Lee KH, Stern PH, Nagai K, Osada H.
    Proc Natl Acad Sci U S A; 2006 Mar 21; 103(12):4729-34. PubMed ID: 16537392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.